NANOSTRING TECHNOLOGIES INC's ticker is NSTG and the CUSIP is 63009R109. A total of 62 filers reported holding NANOSTRING TECHNOLOGIES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,165,000 | -3.8% | 276,447 | -13.8% | 0.22% | +0.9% |
| Q3 2016 | $6,406,000 | +168.9% | 320,600 | +69.6% | 0.22% | +154.1% |
| Q2 2016 | $2,382,000 | -13.2% | 189,016 | +4.8% | 0.08% | -4.5% |
| Q1 2016 | $2,744,000 | +212.5% | 180,312 | +206.9% | 0.09% | +217.9% |
| Q2 2014 | $878,000 | -29.5% | 58,746 | -2.7% | 0.03% | -28.2% |
| Q1 2014 | $1,246,000 | – | 60,346 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 750,000 | $31,673,000 | 4.41% |
| Ally Bridge Group (NY) LLC | 185,000 | $7,813,000 | 2.73% |
| PURA VIDA INVESTMENTS, LLC | 1,183,560 | $49,982,000 | 1.81% |
| Altium Capital Management LP | 146,500 | $6,187,000 | 1.71% |
| Connacht Asset Management LP | 38,789 | $1,638,000 | 1.60% |
| Eversept Partners, LP | 265,695 | $11,220,300 | 0.72% |
| Alyeska Investment Group, L.P. | 1,143,654 | $48,297,000 | 0.56% |
| Orbimed Advisors | 807,100 | $34,084,000 | 0.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 350,719 | $14,811,000 | 0.41% |
| RTW INVESTMENTS, LP | 604,029 | $25,508,000 | 0.37% |